Park Young Hoon
Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.
Blood Res. 2022 Apr 30;57(S1):79-85. doi: 10.5045/br.2022.2022068.
Thrombocytopenia, defined as platelet count <150×10/L, is frequently observed by physicians during pregnancy, with an incidence of approximately 10% of all pregnancies. Most of the cases of thrombocytopenia in pregnancy are due to gestational thrombocytopenia, which does not confer an increased risk of maternal bleeding. However, because other causes can be associated with life-threatening events, such as severe bleeding, that can affect to maternal and fetal outcomes, differentiating other cause of thrombocytopenia, which includes preeclampsia, HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, acute fatty liver of pregnancy, immune thrombocytopenia, hereditary thrombocytopenia, antiphospholipid syndrome, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome, is important. Understanding the mechanisms and recognition of symptoms and signs are important to decide an adequate line of investigation. In this review, the approach to diagnosis and the management of the thrombocytopenia commonly observed in pregnancy are presented.
血小板减少症定义为血小板计数<150×10⁹/L,在孕期常被医生观察到,在所有妊娠中的发生率约为10%。孕期血小板减少症多数病例是由于妊娠期血小板减少症,其不会增加孕产妇出血风险。然而,由于其他病因可能与危及生命的事件相关,如严重出血,这可能影响母婴结局,因此区分血小板减少症的其他病因很重要,这些病因包括子痫前期、HELLP(溶血、肝酶升高、血小板减少)综合征、妊娠急性脂肪肝、免疫性血小板减少症、遗传性血小板减少症、抗磷脂综合征、血栓性血小板减少性紫癜和非典型溶血尿毒综合征。了解其机制以及识别症状和体征对于确定适当的检查方法很重要。在本综述中,介绍了孕期常见血小板减少症的诊断方法和管理。